Search results
Results from the WOW.Com Content Network
The Nov. 19 recall is of 233,003 duloxetine bottles distributed and manufactured by Rising Pharmaceuticals. Both recalls are Class II risks. ... Duloxetine recall: FDA expands recall to more than ...
The Food and Drug Administration (FDA) issued a Class II recall of more than 7,100 bottles of the antidepressant duloxetine due to the possible presence of a carcinogen. Duloxetine belongs to a ...
The Food and Drug Administration has announced a recall for thousands of bottles of the antidepressant duloxetine, sold under brand names like Cymbalta, due to the presence of a chemical that can ...
The recall covers 7,107 bottles of duloxetine, the FDA said. The bottles include 500 delayed-release 20mg capsules. The lot number is 220128, with an expiration date of 12/2024.
The Food and Drug Administration announced a Class II recall for more than 7,000 bottles of an antidepressant due to a chemical.. The recall was initiated earlier this month on Oct. 10. Duloxetine ...
FDA's role under the guidelines is to monitor company recalls and assess the adequacy of a firm's action. After a recall is completed, FDA makes sure that the product is destroyed or suitably reconditioned and investigates why the product was defective. Generally, FDA accepts reports and other necessary recall information submitted by e-mail.
The Food and Drug Administration issued a nationwide recall of single-use eyedrops. One lot of Systane Lubricant Eye Drops Ultra PF, Single Vials On-the-Go, 25 count (Lot 10101) was recalled over ...
The FDA has announced over 20 recalls across the U.S., including food items, cosmetics, drugs, dietary supplements, and medical devices.